Concepedia

Núria Eritja

NE

29

Publications

899

Citations

21

H-Index

2007

Active since

Affiliations

Instituto de Investigación Biomédica de Lleida(Current)

Hospital Universitari Arnau de Vilanova

Universitat de Lleida

Centro de Investigación Biomédica en Red de Cáncer

Bellvitge University Hospital

Núria Eritja is an author at Instituto de Investigación Biomédica de Lleida specializing in medicine, cancer research, and obstetrics.

Top concepts

MedicineGynecologyCell BiologyCancer ResearchTumor BiologyOncologyCancer BiologyPathologyCell SignalingPharmacology

Publications per year

2007–2022

29

Publications

29

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma

Judit Pallarés, Ana Velasco, Núria Eritja et al. · Modern Pathology · 2008 · 72 citations · Full text

Medicine, Promoter Hypermethylation, Pathology +8

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells

David Llobet‐Navàs, Núria Eritja, Mario Encinas et al. · Anti-Cancer Drugs · 2008 · 59 citations

Proteasome Inhibition, Proteasome Inhibitors, Oncology +13

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

Núria Eritja, Mario Encinas, Núria Llecha et al. · Oncogene · 2007 · 54 citations

Cancer Research, Signaling Pathway, Cell Regulation +10

A Novel Three-Dimensional Culture System of Polarized Epithelial Cells to Study Endometrial Carcinogenesis

Núria Eritja, David Llobet‐Navàs, Mónica Domingo et al. · American Journal Of Pathology · 2010 · 52 citations · Full text

Polarized Epithelial Cells, Gynecology, Cell Culture +7

The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

Núria Eritja, Andrée Yeramian, Jacinto Pallarés et al. · European Journal of Cancer · 2010 · 47 citations

Different Mechanisms, Endometrial Cancer Cells, Multikinase Inhibitor Sorafenib +8

Rows per page

1–5 of 29